vs
Side-by-side financial comparison of FULTON FINANCIAL CORP (FULT) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
FULTON FINANCIAL CORP is the larger business by last-quarter revenue ($336.2M vs $207.8M, roughly 1.6× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 28.2%, a 29.2% gap on every dollar of revenue.
Fulton Financial Corporation is an American regional financial services holding company, headquartered in Lancaster, Pennsylvania.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
FULT vs IDYA — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $336.2M | $207.8M |
| Net Profit | $94.8M | $119.2M |
| Gross Margin | — | — |
| Operating Margin | — | 52.2% |
| Net Margin | 28.2% | 57.4% |
| Revenue YoY | 4.2% | — |
| Net Profit YoY | 1.9% | 330.1% |
| EPS (diluted) | $0.55 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $336.2M | — | ||
| Q4 25 | $336.0M | — | ||
| Q3 25 | $334.6M | $207.8M | ||
| Q2 25 | $324.1M | — | ||
| Q1 25 | $318.4M | — | ||
| Q4 24 | $319.6M | — | ||
| Q3 24 | $317.7M | $0 | ||
| Q2 24 | $334.7M | $0 |
| Q1 26 | $94.8M | — | ||
| Q4 25 | $99.0M | — | ||
| Q3 25 | $100.5M | $119.2M | ||
| Q2 25 | $99.2M | — | ||
| Q1 25 | $93.0M | — | ||
| Q4 24 | $68.6M | — | ||
| Q3 24 | $63.2M | $-51.8M | ||
| Q2 24 | $95.0M | $-52.8M |
| Q1 26 | — | — | ||
| Q4 25 | 35.7% | — | ||
| Q3 25 | 38.2% | 52.2% | ||
| Q2 25 | 37.8% | — | ||
| Q1 25 | 36.1% | — | ||
| Q4 24 | 27.0% | — | ||
| Q3 24 | 25.1% | — | ||
| Q2 24 | 30.8% | — |
| Q1 26 | 28.2% | — | ||
| Q4 25 | 29.5% | — | ||
| Q3 25 | 30.0% | 57.4% | ||
| Q2 25 | 30.6% | — | ||
| Q1 25 | 29.2% | — | ||
| Q4 24 | 21.5% | — | ||
| Q3 24 | 19.9% | — | ||
| Q2 24 | 28.4% | — |
| Q1 26 | $0.55 | — | ||
| Q4 25 | $0.53 | — | ||
| Q3 25 | $0.53 | $1.33 | ||
| Q2 25 | $0.53 | — | ||
| Q1 25 | $0.49 | — | ||
| Q4 24 | $0.36 | — | ||
| Q3 24 | $0.33 | $-0.60 | ||
| Q2 24 | $0.52 | $-0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.5B | $1.1B |
| Total Assets | $32.2B | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $786.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $920.0M | ||
| Q2 24 | — | $701.7M |
| Q1 26 | $3.5B | — | ||
| Q4 25 | $3.5B | — | ||
| Q3 25 | $3.4B | $1.1B | ||
| Q2 25 | $3.3B | — | ||
| Q1 25 | $3.3B | — | ||
| Q4 24 | $3.2B | — | ||
| Q3 24 | $3.2B | $1.2B | ||
| Q2 24 | $3.1B | $931.7M |
| Q1 26 | $32.2B | — | ||
| Q4 25 | $32.1B | — | ||
| Q3 25 | $32.0B | $1.2B | ||
| Q2 25 | $32.0B | — | ||
| Q1 25 | $32.1B | — | ||
| Q4 24 | $32.1B | — | ||
| Q3 24 | $32.2B | $1.2B | ||
| Q2 24 | $31.8B | $973.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $142.2M |
| Free Cash FlowOCF − Capex | — | $142.2M |
| FCF MarginFCF / Revenue | — | 68.4% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $304.5M | — | ||
| Q3 25 | $116.1M | $142.2M | ||
| Q2 25 | $91.7M | — | ||
| Q1 25 | $703.0K | — | ||
| Q4 24 | $416.6M | — | ||
| Q3 24 | $-22.0M | $-49.2M | ||
| Q2 24 | $157.8M | $-32.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $142.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-49.7M | ||
| Q2 24 | — | $-33.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 68.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.08× | — | ||
| Q3 25 | 1.16× | 1.19× | ||
| Q2 25 | 0.92× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 6.07× | — | ||
| Q3 24 | -0.35× | — | ||
| Q2 24 | 1.66× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
